Cue Health to Announce Third Quarter 2023 Financial Results
25 Outubro 2023 - 5:01PM
Business Wire
Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology
company, announced today that it will release its third quarter
2023 financial results on Wednesday, November 8, 2023. In
conjunction with the release, Cue will host a conference call and
webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time
to discuss its financial results and recent highlights.
To access the live call via telephone, please register in
advance using the link here. Upon registering, each participant
will receive an email confirmation with dial-in numbers and a
unique personal PIN that can be used to join the call.
The live webinar of the call may be accessed by visiting the
Events section of the Company’s website at investors.cuehealth.com.
A replay of the webinar will be available on the Company’s website
shortly after the conclusion of the call.
About Cue Health
Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology
company that uses diagnostic-enabled care to empower people to live
their healthiest lives. The Cue Health platform offers individuals
and healthcare providers convenient and personalized access to
lab-quality diagnostic tests at home and at the point-of-care, as
well as on-demand telehealth consultations and treatment options
for a wide range of health and wellness needs. Cue’s customers
include federal and state public sector agencies and the private
sector, which includes healthcare providers, enterprises, and
individual consumers. Cue received De Novo authorization from the
U.S. Food and Drug Administration (FDA) for its COVID-19 test,
which became the first home use respiratory test to receive this
FDA approval. Cue also received Emergency Use Authorization from
the FDA for its molecular mpox test at the point-of-care. To
further expand its test menu, Cue has made other submissions that
are now under review by the FDA, including for the Cue® Flu A/B +
COVID-19 Molecular Test and the Cue® RSV Molecular Test, both of
which are designed for at-home and point-of-care use. Cue, founded
in 2010, owns over 100 patents and is headquartered in San Diego.
For more information, please visit www.cuehealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231025996867/en/
Lorna Williams ir@cuehealth.com 858-667-4934 (ext. 1104)
Cue Health press@cuehealth.com
Cue Health (NASDAQ:HLTH)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Cue Health (NASDAQ:HLTH)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024